Trial intelligence / Profile preview

Pegylated Somatropin vs Jintropin AQ in Children with Growth Hormone Deficiency

NCT01495468Phase 3Completed

Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Start
Mar 2007
Primary completion
Jan 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of peg-somatropin in growth hormone deficiency (GHD), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Mar 2007; status: completed.

02

Drugs

peg-somatropin
03

Conditions

growth hormone deficiency (GHD)

Beyond the preview

Go deeper on NCT01495468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01495468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call